BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$89.91
+3.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 12.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.14x
- Price / sales
- 8.36x
- Price / cash flow
- -81.52x
Enterprise value
- Enterprise value
- $11.6B
- EV / sales
- 4.28x
- EV / EBITDA
- -19.59x
- EV / EBIT
- -5.99x
- Market cap
- $22.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026